Phenotypic Pharmaceuticals LLC entered the industry of Commercial Medical Research in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Lance Smith by calling (858) 837-0108 during business hours. You can also write to the business’ Single Location at 8717 Creekwood Lane, San Diego, California CA 92129. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Phenotypic Pharmaceuticals LLC |
| Representative: | Lance Smith |
| Place of Business: | 8717 Creekwood Lane, San Diego, CA 92129 |
| Contact Number: | (858) 837-0108 |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2009 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Phenotypic Pharmaceuticals LLC is a company operating from San Diego, California providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2009 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Phenotypic Pharmaceuticals LLC has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Lance Smith at (858) 837-0108 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 8717 Creekwood Lane in San Diego, California 92129 and can be engaged online through the company website at , the company Twitter , and Facebook page .